Molecular Diagnostic Equipment.

Molecular diagnostics in Nepal is moving in two directions at once: high-throughput reference labs running real-time PCR and line probe assays for infectious disease confirmation, and decentralized point-of-care platforms bringing nucleic acid testing to district hospitals, primary care clinics, and remote outreach programmes. JHS Analytic Traders supplies platforms across both tiers — high-volume rt-PCR thermocyclers and ELISA-coupled molecular workflows for tertiary labs, and cartridge-based portable systems for near-patient testing where sample transport to a central lab is not practical.

Our molecular diagnostic portfolio supports the diseases that matter most for Nepal's clinical and public-health priorities: HPV / cervical cancer screening, respiratory pathogens (SARS-CoV-2, influenza, RSV), hepatitis B and C viral load, HIV, sexually transmitted infections, gastrointestinal pathogens, meningitis/encephalitis, and tuberculosis. JHS leads with two flagship platforms — point-of-care portable PCR for decentralised testing, and reference-lab syndromic multiplex PCR for tertiary hospitals.